Clinical Trials Browser

Phase NA × Withdrawn × Sorafenib × Clear all

NCT02691780 2019-12-30

Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

Phase NA Withdrawn

Other solid neoplasm

Refractory Solid Tumors